Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Roberto Zenteno-Cuevas. (2017) Successes and failures in human tuberculosis vaccine development. Expert Opinion on Biological Therapy 17:12, pages 1481-1491.
Read now
Read now
Harald Fjällbrant, Malin Ridell & Lars Olof larsson. (2008) BCG scar and tuberculin reactivity in children and adults. Scandinavian Journal of Infectious Diseases 40:5, pages 387-392.
Read now
Read now
BM Buddle, FE Aldwell, DL Keen, NA Parlane, KL Hamel & GW
de Lisle. (2006) Oral vaccination of brushtail possums with BCG: Investigation into factors that may influence vaccine efficacy and determination of duration of protection. New Zealand Veterinary Journal 54:5, pages 224-230.
Read now
Read now
Anne S De Groot & Rino Rappuoli. (2004) Genome-derived vaccines. Expert Review of Vaccines 3:1, pages 59-76.
Read now
Read now
Articles from other publishers (29)
Paulo R. Z. Antas, Andreon S. M. da Silva, Lawrence H. P. Albuquerque, Matheus R. Almeida, Evelyn N. G. S. Pereira, Luiz R. R. Castello-Branco & Carlos G. G. de Ponte. (2022) The BCG Moreau Vaccine Upregulates In Vitro the Expression of TLR4, B7-1, Dectin-1 and EP2 on Human Monocytes. Vaccines 11:1, pages 86.
Crossref
Crossref
Timothy Lahey & C. Fordham von Reyn. 2021. Tuberculosis and Nontuberculous Mycobacterial Infections. Tuberculosis and Nontuberculous Mycobacterial Infections
162
181
.
Jyoti Yadav, Sonali Verma, Darshna Chaudhary, Pawan K. Jaiwal & Ranjana Jaiwal. (2019) Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines. Current Pharmaceutical Biotechnology 20:6, pages 446-458.
Crossref
Crossref
Timothy Lahey & C. Fordham von Reyn. 2017. Tuberculosis and Nontuberculous Mycobacterial Infections. Tuberculosis and Nontuberculous Mycobacterial Infections
187
209
.
Domenico Bonamonte, Angela Filoni & Gianni Angelini. 2017. Mycobacterial Skin Infections. Mycobacterial Skin Infections
141
151
.
Timothy Lahey & C. Fordham von Reyn. (2016)
Mycobacterium bovis
BCG and New Vaccines for the Prevention of Tuberculosis
. Microbiology Spectrum 4:5.
Crossref
Crossref
Abdallah M. Abdallah, Grant A. Hill-Cawthorne, Thomas D. Otto, Francesc Coll, José Afonso Guerra-Assunção, Ge Gao, Raeece Naeem, Hifzur Ansari, Tareq B. Malas, Sabir A. Adroub, Theo Verboom, Roy Ummels, Huoming Zhang, Aswini Kumar Panigrahi, Ruth McNerney, Roland Brosch, Taane G. Clark, Marcel A. Behr, Wilbert Bitter & Arnab Pain. (2015) Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations. Scientific Reports 5:1.
Crossref
Crossref
Timothy C Barnett, Jin Yan Lim, Amelia T Soderholm, Tania Rivera-Hernandez, Nicholas P West & Mark J Walker. (2015) Host–pathogen interaction during bacterial vaccination. Current Opinion in Immunology 36, pages 1-7.
Crossref
Crossref
Thomas G. Evans, Michael J. Brennan, Lew Barker & Jelle Thole. (2013) Preventive vaccines for tuberculosis. Vaccine 31, pages B223-B226.
Crossref
Crossref
Kim Connelly Smith, Ian M. Orme & Jeffrey R. Starke. 2013. Vaccines. Vaccines
789
811
.
Andrew Keyser, JoLynn M. Troudt, Jennifer L. Taylor & Angelo A. Izzo. (2011) BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity. Vaccine 29:50, pages 9308-9315.
Crossref
Crossref
Patricia L. Semple, Marcia Watkins, Virginia Davids, Alan M. Krensky, Willem A. Hanekom, Gilla Kaplan & Stanley Ress. (2011) Induction of Granulysin and Perforin Cytolytic Mediator Expression in 10-Week-Old Infants Vaccinated with BCG at Birth. Clinical and Developmental Immunology 2011, pages 1-10.
Crossref
Crossref
Jeffrey R. Starke & Andrea T. Cruz. 2011. Infectious Diseases of the Fetus and Newborn. Infectious Diseases of the Fetus and Newborn
577
600
.
Larissa Lumi Watanabe Ishikawa, Thaís Graziela Donegá França, Fernanda Chiuso-Minicucci, Sofia Fernanda Gonçalves Zorzella-Pezavento, Nelson Mendes Marra, Paulo Câmara Marques Pereira, Célio Lopes Silva & Alexandrina Sartori. (2009) Dietary restriction abrogates antibody production induced by a DNA vaccine encoding the mycobacterial 65 kDa heat shock protein. Genetic Vaccines and Therapy 7:1.
Crossref
Crossref
Nicole Ritz & Nigel Curtis. (2009) Mapping the global use of different BCG vaccine strains. Tuberculosis 89:4, pages 248-251.
Crossref
Crossref
S. M. Irwin, A. Goodyear, A. Keyser, R. Christensen, J. M. Troudt, J. L. Taylor, A. Bohsali, V. Briken & A. A. Izzo. (2008)
Immune Response Induced by Three
Mycobacterium bovis
BCG Substrains with Diverse Regions of Deletion in a C57BL/6 Mouse Model
. Clinical and Vaccine Immunology 15:5, pages 750-756.
Crossref
Crossref
Hazel M. Dockrell, Patricia Gorak‐Stolinska & Laura C. Rodrigues. 2008. Handbook of Tuberculosis. Handbook of Tuberculosis
245
276
.
Kim Connelly Smith, Ian M. Orme & Jeffrey R. Starke. 2008. Vaccines. Vaccines
857
885
.
Mamta Kalra, Ajay Grover, Neena Mehta, Jaspreet Singh, Jaspreet Kaur, Suraj B. Sable, Digambar Behera, Pawan Sharma, Indu Verma & G.K. Khuller. (2007) Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice. Clinical Immunology 125:2, pages 173-183.
Crossref
Crossref
D. Neil Wedlock, Michel Denis, H. Martin Vordermeier, R. Glyn Hewinson & Bryce M. Buddle. (2007) Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNγ post-vaccination, but induce similar levels of protection against bovine tuberculosis. Veterinary Immunology and Immunopathology 118:1-2, pages 50-58.
Crossref
Crossref
Patricia Gorak-Stolinska, Rosemary E. Weir, Sian Floyd, Maeve K. Lalor, Sally Stenson, Keith Branson, Rose Blitz, Sarah Luke, Bernadette Nazareth, Anne Ben-Smith, Paul E.M. Fine & Hazel M. Dockrell. (2006) Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: Comparison with Glaxo-Evans 1077 BCG vaccine. Vaccine 24:29-30, pages 5726-5733.
Crossref
Crossref
Antonia Isabel Castillo-RodalMauricio Castañón-ArreolaRogelio Hernández-PandoJuan José CalvaEduardo Sada-Díaz & Yolanda López-Vidal. (2006)
Mycobacterium bovis
BCG Substrains Confer Different Levels of Protection against
Mycobacterium tuberculosis
Infection in a BALB/c Model of Progressive Pulmonary Tuberculosis
. Infection and Immunity 74:3, pages 1718-1724.
Crossref
Crossref
Jeffrey R. Starke. 2006. Infectious Diseases of the Fetus and Newborn Infant. Infectious Diseases of the Fetus and Newborn Infant
581
601
.
T. Mark Doherty & Peter Andersen. (2005) Vaccines for Tuberculosis: Novel Concepts and Recent Progress. Clinical Microbiology Reviews 18:4, pages 687-702.
Crossref
Crossref
Peter Andersen & T. Mark Doherty. (2005) The success and failure of BCG — implications for a novel tuberculosis vaccine. Nature Reviews Microbiology 3:8, pages 656-662.
Crossref
Crossref
Hamdan Al-Jahdali, Ziad A. Memish & Dick Menzies. (2005) The utility and interpretation of tuberculin skin tests in the Middle East. American Journal of Infection Control 33:3, pages 151-156.
Crossref
Crossref
T. Mark Doherty & Peter Andersen. (2002) Tuberculosis vaccine development. Current Opinion in Pulmonary Medicine 8:3, pages 183-187.
Crossref
Crossref
Serge Mostowy & Marcel A. Behr. (2002) Comparative Genomics in the Fight Against Tuberculosis. American Journal of PharmacoGenomics 2:3, pages 189-196.
Crossref
Crossref
. (2001) Current Awareness on Comparative and Functional Genomics. Comparative and Functional Genomics 2:6, pages 401-412.
Crossref
Crossref